Share on Pinterest The FDA has approved an esketamine nasal spray for the treatment of depression cases that do not respond to other therapeutic approaches. Image credit: Koldunov/Getty Images.

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of MDD in those who have not responded to at least two oral antidepressants. Hundreds of ...

Below is Validea's guru fundamental report for AUTOZONE INC (AZO). Of the 22 guru strategies we follow, AZO rates highest using our Multi-Factor Investor model based on the published strategy of ...

BBY Best Buy Co., Inc.

Canadian Tire Corp. Ltd. 4.51% $9.51B ...

The FDA's expanded approval will allow the drug to be more accessible with insurance. Parkside Psychiatric Hospital in Tulsa has an on-site Spravato outpatient clinic that sees over 20 patients ...

After hours: 28 January at 6:45:00 pm GMT-5 ...

Can tell you results 6 days sooner than your missed period (5 days before you expect your period)[1] Over 99% accurate from the day you expect your period [2] Extra wide tip for easy sampling 3 ...